Literature DB >> 12753742

Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation.

Daniel F Legler1, Olivier Micheau, Marie-Agnès Doucey, Jürg Tschopp, Claude Bron.   

Abstract

Engagement of TNF receptor 1 by TNFalpha activates the transcription factor NF-kappaB but can also induce apoptosis. Here we show that upon TNFalpha binding, TNFR1 translocates to cholesterol- and sphingolipid-enriched membrane microdomains, termed lipid rafts, where it associates with the Ser/Thr kinase RIP and the adaptor proteins TRADD and TRAF2, forming a signaling complex. In lipid rafts, TNFR1 and RIP are ubiquitylated. Furthermore, we provide evidence that translocation to lipid rafts precedes ubiquitylation, which leads to the degradation via the proteasome pathway. Interfering with lipid raft organization not only abolishes ubiquitylation but switches TNFalpha signaling from NF-kappaB activation to apoptosis. We suggest that lipid rafts are crucial for the outcome of TNFalpha-activated signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753742     DOI: 10.1016/s1074-7613(03)00092-x

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  129 in total

1.  Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB.

Authors:  Hasem Habelhah; Shoichi Takahashi; Ssang-Goo Cho; Takayuki Kadoya; Toshiki Watanabe; Ze'ev Ronai
Journal:  EMBO J       Date:  2004-01-08       Impact factor: 11.598

2.  Distinct mechanisms determine the patterns of differential activation of H-Ras, N-Ras, K-Ras 4B, and M-Ras by receptors for growth factors or antigen.

Authors:  Annette Ehrhardt; Muriel D David; Götz R A Ehrhardt; John W Schrader
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  The tumor necrosis factor receptor stalk regions define responsiveness to soluble versus membrane-bound ligand.

Authors:  Christine Richter; Sylvia Messerschmidt; Gerlinde Holeiter; Jessica Tepperink; Sylvia Osswald; Andrea Zappe; Marcus Branschädel; Verena Boschert; Derek A Mann; Peter Scheurich; Anja Krippner-Heidenreich
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

Review 4.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

5.  γ-Secretase Activity Is Required for Regulated Intramembrane Proteolysis of Tumor Necrosis Factor (TNF) Receptor 1 and TNF-mediated Pro-apoptotic Signaling.

Authors:  Jyoti Chhibber-Goel; Caroline Coleman-Vaughan; Vishal Agrawal; Neha Sawhney; Emer Hickey; James C Powell; Justin V McCarthy
Journal:  J Biol Chem       Date:  2016-01-11       Impact factor: 5.157

Review 6.  Piecing it together: Unraveling the elusive structure-function relationship in single-pass membrane receptors.

Authors:  Christopher C Valley; Andrew K Lewis; Jonathan N Sachs
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-01-12       Impact factor: 3.747

Review 7.  Lipid raft: A floating island of death or survival.

Authors:  Kimberly S George; Shiyong Wu
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-24       Impact factor: 4.219

8.  Herpes simplex virus 1 ICP6 impedes TNF receptor 1-induced necrosome assembly during compartmentalization to detergent-resistant membrane vesicles.

Authors:  Mohammad Ali; Linda Roback; Edward S Mocarski
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

Review 9.  Signaling components of redox active endosomes: the redoxosomes.

Authors:  Fredrick D Oakley; Duane Abbott; Qiang Li; John F Engelhardt
Journal:  Antioxid Redox Signal       Date:  2009-06       Impact factor: 8.401

10.  Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells.

Authors:  Marzenna Blonska; Yun You; Romas Geleziunas; Xin Lin
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.